Advances in the diagnosis and management of well-differentiated neuroendocrine neoplasms
Neuroendocrine neoplasms constitute a diverse group of tumors that derive from the
sensory and secretory neuroendocrine cells and predominantly arise within the pulmonary …
sensory and secretory neuroendocrine cells and predominantly arise within the pulmonary …
Recent updates on grading and classification of neuroendocrine tumors
JY Kim, SM Hong, JY Ro - Annals of diagnostic pathology, 2017 - Elsevier
Neuroendocrine tumors (NETs) are originating from neuroendocrine cells in diffuse
endocrine systems. NETs are diagnosed by characteristic histologic features and …
endocrine systems. NETs are diagnosed by characteristic histologic features and …
ENETS consensus guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and …
M Pavel, E Baudin, A Couvelard, E Krenning… - …, 2012 - karger.com
Therapeutic approaches for management of metastatic disease include surgical, medical,
radiological and nuclear medicine strategies. More recently, novel molecular targeted drugs …
radiological and nuclear medicine strategies. More recently, novel molecular targeted drugs …
ENETS consensus guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes
RT Jensen, G Cadiot, ML Brandi, WW De Herder… - …, 2012 - karger.com
Gastrinomas are neuroendocrine neoplasms, usually located in the duodenum or pancreas,
that secrete gastrin and cause a clinical syndrome known as Zollinger-Ellison syndrome …
that secrete gastrin and cause a clinical syndrome known as Zollinger-Ellison syndrome …
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)
JK Ramage, A Ahmed, J Ardill, N Bax, DJ Breen… - gut, 2012 - gut.bmj.com
These guidelines update previous guidance published in 2005. They have been revised by
a group who are members of the UK and Ireland Neuroendocrine Tumour Society with …
a group who are members of the UK and Ireland Neuroendocrine Tumour Society with …
ENETS consensus guidelines for the standards of care in neuroendocrine tumors: pathology-diagnosis and prognostic stratification
Abstract The European Neuroendocrine Tumor Society (ENETS) proposed standard of care
guidelines for pathology in 2009. Since then, profound changes in the classification have …
guidelines for pathology in 2009. Since then, profound changes in the classification have …
ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non …
M Falconi, DK Bartsch, B Eriksson, G Klöppel… - …, 2012 - karger.com
The WHO 2010 classification [1] distinguishes between well-differentiated neuroendocrine
tumors (NETs) and poorly differentiated neuroendocrine carcinomas (NECs) of small or …
tumors (NETs) and poorly differentiated neuroendocrine carcinomas (NECs) of small or …
NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas
Well-differentiated neuroendocrine tumors (NETs) of the stomach and pancreas represent 2
major subtypes of gastrointestinal NETs. Historically, there has been little consensus on the …
major subtypes of gastrointestinal NETs. Historically, there has been little consensus on the …
Incidence of gastroenteropancreatic neuroendocrine tumours: a systematic review of the literature
M Fraenkel, M Kim, A Faggiano… - Endocrine-related …, 2014 - erc.bioscientifica.com
Based on the current medical literature, the worldwide incidence of neuroendocrine tumours
(NETs) seems to have increased; however, a systematic literature overview is lacking. This …
(NETs) seems to have increased; however, a systematic literature overview is lacking. This …
Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification …
MB Niederle, M Hackl, K Kaserer… - Endocrine-related …, 2010 - erc.bioscientifica.com
Germline inactivating mutations of isoform 4 of phosphodiesterase (PDE) 11A (coded by the
PDE11A gene) have been associated with familial adrenocortical tumors and familial …
PDE11A gene) have been associated with familial adrenocortical tumors and familial …